WWB-2603-N3120

Semaglutide · 2 mg declared · Wuhan Wansheng Biotechnology Co., Ltd. · manufactured 09 Mar 2026

CHARACTERISED

Lot code: WWB-2603-N3120
Supplier: WWB — Wuhan Wansheng Biotechnology Co., Ltd.
Compound: Semaglutide
Compound class: Incretin analogues and co-agonists
Declared label claim: 2mg
Manufacture date: 09 Mar 2026
Index quarter: 2026-Q2
Independent assays: 15
Laboratories involved: Janoshik, Medutest, VendorInvestigate, Nordanalyt, PeptideMeter, Kestrel
Provenance mix: Buyer-sourced ×3 · Supplier-supplied ×12

Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 15

Median purity 98.98% n=15

Spread (max − min) 1.94pp n=15

Standard deviation 0.511pp n=15

Figure 1. This lot's independent purity results against the whole Semaglutide record set in the index. The vertical line is the index acceptance specification for the incretin analogues and co-agonists class, 97.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.

Section 2

Member reports 15

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

Report	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2026-041283	WWB-2603-N3120	Janoshik	2026-Q2	98.24	6.54	—	Supplier-supplied	2	MARGINAL
AX-2026-041284	WWB-2603-N3120	Medutest	2026-Q2	99.55	6.01	—	Supplier-supplied	2	MARGINAL
AX-2026-041285	WWB-2603-N3120	Janoshik	2026-Q2	98.67	7.21	96.1	Supplier-supplied	2	MARGINAL
AX-2026-041286	WWB-2603-N3120	VendorInvestigate	2026-Q2	97.99	6.65	94.7	Buyer-sourced	2	MARGINAL
AX-2026-041287	WWB-2603-N3120	Nordanalyt	2026-Q2	99.04	6.47	—	Supplier-supplied	2	MARGINAL
AX-2026-041288	WWB-2603-N3120	Janoshik	2026-Q2	99.45	6.16	90.1	Supplier-supplied	2	MARGINAL
AX-2026-041289	WWB-2603-N3120	PeptideMeter	2026-Q2	98.37	6.09	101.2	Supplier-supplied	2	MARGINAL
AX-2026-041290	WWB-2603-N3120	Nordanalyt	2026-Q2	98.96	6.85	94.8	Supplier-supplied	2	MARGINAL
AX-2026-041291	WWB-2603-N3120	Nordanalyt	2026-Q2	99.33	6.56	—	Supplier-supplied	2	MARGINAL
AX-2026-041292	WWB-2603-N3120	PeptideMeter	2026-Q2	98.81	6.41	93.9	Supplier-supplied	2	MARGINAL
AX-2026-041293	WWB-2603-N3120	VendorInvestigate	2026-Q2	98.70	5.90	97.7	Buyer-sourced	2	MARGINAL
AX-2026-041294	WWB-2603-N3120	VendorInvestigate	2026-Q2	98.98	6.20	—	Buyer-sourced	3	FAIL
AX-2026-041295	WWB-2603-N3120	PeptideMeter	2026-Q2	99.00	6.23	—	Supplier-supplied	2	MARGINAL
AX-2026-041296	WWB-2603-N3120	Kestrel	2026-Q2	99.93	6.58	103.7	Supplier-supplied	2	MARGINAL
AX-2026-041297	WWB-2603-N3120	PeptideMeter	2026-Q2	99.05	6.39	96.5	Supplier-supplied	2	MARGINAL

Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

Laboratory	Reports	Purity results (% area)	Median	Gradient	Published bias (pp)	Bias-adjusted
Janoshik	3	98.24, 98.67, 99.45	98.67	30min	+0.00	98.67
Medutest	1	99.55	99.55	25min	+0.08	99.47
VendorInvestigate	3	97.99, 98.70, 98.98	98.70	32min	-0.11	98.81
Nordanalyt	3	99.04, 98.96, 99.33	99.04	35min	+0.02	99.02
PeptideMeter	4	98.37, 98.81, 99.00, 99.05	98.91	28min	-0.05	98.95
Kestrel	1	99.93	99.93	15min	+0.24	99.69

This lot contributes 15 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

Figure	Supplier COA	This report	Index note
Purity (% area)	99.46	98.24	divergence +0.48 pp vs batch median
Total impurities (% area)	0.54	1.76
Largest single impurity (% area)	0.22	0.89
Water (%)	4.5	6.54
Counter-ion (%)	5.5	8.65
Peptide content (%w/w)	89.4	not determined
Endotoxin (EU/mg)	not stated	not determined
Method stated on certificate	YES	—	column, gradient and wavelength given

Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurity	Reported in	Median % area	Range
des-AEEA semaglutide (−145 Da)	15 / 15	0.46	0.04–0.89
[D-Aib8]-diastereomer	15 / 15	0.27	0.03–0.69
des-His1 truncate (−137 Da)	14 / 15	0.09	0.04–0.37
C18 diacid mono-ester	12 / 15	0.04	0.02–0.07
tBu-protected residual (+56 Da)	8 / 15	0.15	0.10–0.19
semaglutide dimer	6 / 15	0.10	0.08–0.15
deamidated (Asn→Asp, +1 Da)	5 / 15	0.02	0.01–0.03

Section 7

Reproducibility across independent tests

Member reports 15

By laboratory

The supplier's certificate for this lot

Impurity fingerprint

What this rollup does not establish